NOVAVAX INC - 8-K Filing
Novavax reports Q3 2026 revenue of $68 million and raises full-year adjusted total revenue guidance to $385-$415 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $NVAX
Read the full article at SEC EDGAR
Part of the story CNO Financial Group, Inc. - 8-K Filing (15 articles)